No Data
No Data
Asia-Pacific Metagenomics Market Research 2024-2033 With Competitive Analysis of Leading Players - BGI Genomics, MGI Tech, and Macrogen - ResearchAndMarkets.com
Express News | Saudi National Medical Procurement Company visits bgi genomics to deepen cooperation in precision medical testing.
BGI: Report for the third quarter of 2024
Express News | bgi genomics: a net loss of 0.124 billion yuan in the first three quarters.
Express News | Bgi genomics: The net income was a loss of 0.124 billion yuan in the first three quarters.
Existing for over 14 years, Yunfeng RMB Fund Phase I may successfully come to an end.
①Shanghai Yunfeng has had a commercial change, with the registered capital reduced from 0.29 billion RMB to 10 million RMB; ②Yunfeng Fund stated that it has currently established five batches of RMB investment funds and four batches of USD investment funds. The settlement of early funds indicates that the company is further optimizing its strategy and portfolio, strengthening the investment layout of subsequent funds.
No Data
No Data